Durban to get world’s most advanced TB research centre
The world’s ‘most advanced research centre’ dedicated to tuberculosis and HIV research is going to be built at the University of KwaZulu-Natal within months.
Some R308-million has been set aside for the six-storey building and 10 years’ worth of research, according to an announcement made simultaneously in Washington and Durban yesterday (19 March).
KwaZulu-Natal is the epicentre of HIV infection in the world, while 58 health facilities in the province had recorded cases of the incurable extensively drug-resistant (XDR) TB by mid-2007.
Scientists from the US and South Africa will lead the research programmes at the centre, which will also act as a training facility for African scientists.
‘We want to be part of the brain gain, ‘ explains the university’s vice-chancellor, Professor Salim Abdool Karim, one of the main drivers of the centre.
‘This centre will enable us to make a gigantic leap forward in research. We would never have been able to do so without a massive injection of resources. We will be dealing with very dangerous, infectious organisms and who would want to work with such things without such safety facilities?’ added Abdool Karim.
Two floors of the centre will be taken up by state-of-the-art Level 3 bio-safety laboratories that will enable scientists to work safely with highly dangerous drug-resistant TB bacteria. Only laboratories dealing with haemorraghic fevers (such as ebola) have a higher safety level.
The research aims of the centre will be three-fold, according to Professor Willem Sturm, medical school dean and interim director of the centre.
These are:
· The development of rapid tests to diagnose drug-resistant TB. Some newer tests are more rapid, but miss resistant strains or require too much high-tech equipment.
· Identifying the genetic characteristics of drug resistant strains of TB in an attempt to understand ‘what made TB more aggressive and resistant’ over the past decade.
· Analysing people’s immune responses to tuberculosis, particularly among people infected with HIV.
· Studying recurrent tuberculosis in people with HIV to ascertain whether the patient has become reinfected with TB or whether latent TB in the patient has become reactivated.
Patient facilities at Church of Scotland and McCord Hospitals and Prince Cyril Zulu Clinic will also be improved as part of the research programme.
Construction begins in September and will change the face of the medical school, the centre is expected to be completed by the end of 2010.
‘Our cross-Atlantic partnership reflects a shared view that direct and substantial investment in basic, clinical, and transnational research in the heart of the pandemics of HIV and TB will yield significant discoveries that will alleviate the human suffering caused by these diseases,’ said ‘Thomas R. Cech, president of the Howard Hughes Medical Institute (HHMI), which is the main donor.
Other funding comes from Lifelab and the university itself. ‘ Health-e News Service.
Author
-
Health-e News is South Africa's dedicated health news service and home to OurHealth citizen journalism. Follow us on Twitter @HealtheNews
Republish this article
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
Unless otherwise noted, you can republish our articles for free under a Creative Commons license. Here’s what you need to know:
-
You have to credit Health-e News. In the byline, we prefer “Author Name, Publication.” At the top of the text of your story, include a line that reads: “This story was originally published by Health-e News.” You must link the word “Health-e News” to the original URL of the story.
-
You must include all of the links from our story, including our newsletter sign up link.
-
If you use canonical metadata, please use the Health-e News URL. For more information about canonical metadata, click here.
-
You can’t edit our material, except to reflect relative changes in time, location and editorial style. (For example, “yesterday” can be changed to “last week”)
-
You have no rights to sell, license, syndicate, or otherwise represent yourself as the authorized owner of our material to any third parties. This means that you cannot actively publish or submit our work for syndication to third party platforms or apps like Apple News or Google News. Health-e News understands that publishers cannot fully control when certain third parties automatically summarise or crawl content from publishers’ own sites.
-
You can’t republish our material wholesale, or automatically; you need to select stories to be republished individually.
-
If you share republished stories on social media, we’d appreciate being tagged in your posts. You can find us on Twitter @HealthENews, Instagram @healthenews, and Facebook Health-e News Service.
You can grab HTML code for our stories easily. Click on the Creative Commons logo on our stories. You’ll find it with the other share buttons.
If you have any other questions, contact info@health-e.org.za.
Durban to get world’s most advanced TB research centre
by healthe, Health-e News
March 19, 2009